• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

COVID-19 Impact on Inhalation Spray-Based Drugs Market, Global Research Reports 2020-2021

report cover
  • 22 May 2020
  • Healthcare
  • 94 Pages
  • Report Code: 24LS-3508
  • Formate :   
Download FREE Report Sample Download PDF File

COVID 19 Impact Inhalati Spray Based Drugs Market Reports -MARKET ADVISORY SERVICES

This report covers market size and forecasts of Inhalation Spray-Based Drugs, including the following market information:
Global Inhalation Spray-Based Drugs Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Inhalation Spray-Based Drugs Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Inhalation Spray-Based Drugs Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)
Global Inhalation Spray-Based Drugs Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players
Major competitors identified in this market include Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.), Allergan Plc., CHIESI Farmaceutici S.p.A, Serenity Pharmaceuticals, LLC, Boehringer Ingelheim GmbH, GlaxoSmithKline plc, Teva Pharmaceuticals, AstraZeneca Plc., Opko Health, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Corticosteroids
Bronchodilators
Antihistamines
Combination Drugs

Based on the Application:
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Clinics
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Inhalation Spray-Based Drugs Industry
1.7 COVID-19 Impact: Inhalation Spray-Based Drugs Market Trends

2 Global Inhalation Spray-Based Drugs Quarterly Market Size Analysis
2.1 Inhalation Spray-Based Drugs Business Impact Assessment - COVID-19
2.1.1 Global Inhalation Spray-Based Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Inhalation Spray-Based Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Inhalation Spray-Based Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges

3 Quarterly Competitive Assessment, 2020
3.1 Global Inhalation Spray-Based Drugs Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Inhalation Spray-Based Drugs Factory Price by Manufacturers
3.3 Location of Key Manufacturers Inhalation Spray-Based Drugs Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Inhalation Spray-Based Drugs Market
3.5 Key Manufacturers Inhalation Spray-Based Drugs Product Offered
3.6 Mergers & Acquisitions, Expansion Plans

4 Impact of Covid-19 on Inhalation Spray-Based Drugs Segments, By Type
4.1 Introduction
1.4.1 Corticosteroids
1.4.2 Bronchodilators
1.4.3 Antihistamines
1.4.4 Combination Drugs
4.2 By Type, Global Inhalation Spray-Based Drugs Market Size, 2019-2021
4.2.1 By Type, Global Inhalation Spray-Based Drugs Market Size by Type, 2020-2021
4.2.2 By Type, Global Inhalation Spray-Based Drugs Price, 2020-2021

5 Impact of Covid-19 on Inhalation Spray-Based Drugs Segments, By Application
5.1 Overview
5.5.1 Hospital Pharmacy
5.5.2 Retail Pharmacy
5.5.3 Drug Stores
5.5.4 Clinics
5.2 By Application, Global Inhalation Spray-Based Drugs Market Size, 2019-2021
5.2.1 By Application, Global Inhalation Spray-Based Drugs Market Size by Application, 2019-2021
5.2.2 By Application, Global Inhalation Spray-Based Drugs Price, 2020-2021

6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa

7 Company Profiles
7.1 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.)
7.1.1 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Business Overview
7.1.2 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.1.3 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Inhalation Spray-Based Drugs Product Introduction
7.1.4 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Response to COVID-19 and Related Developments
7.2 Allergan Plc.
7.2.1 Allergan Plc. Business Overview
7.2.2 Allergan Plc. Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.2.3 Allergan Plc. Inhalation Spray-Based Drugs Product Introduction
7.2.4 Allergan Plc. Response to COVID-19 and Related Developments
7.3 CHIESI Farmaceutici S.p.A
7.3.1 CHIESI Farmaceutici S.p.A Business Overview
7.3.2 CHIESI Farmaceutici S.p.A Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.3.3 CHIESI Farmaceutici S.p.A Inhalation Spray-Based Drugs Product Introduction
7.3.4 CHIESI Farmaceutici S.p.A Response to COVID-19 and Related Developments
7.4 Serenity Pharmaceuticals, LLC
7.4.1 Serenity Pharmaceuticals, LLC Business Overview
7.4.2 Serenity Pharmaceuticals, LLC Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.4.3 Serenity Pharmaceuticals, LLC Inhalation Spray-Based Drugs Product Introduction
7.4.4 Serenity Pharmaceuticals, LLC Response to COVID-19 and Related Developments
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Business Overview
7.5.2 Boehringer Ingelheim GmbH Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.5.3 Boehringer Ingelheim GmbH Inhalation Spray-Based Drugs Product Introduction
7.5.4 Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments
7.6 GlaxoSmithKline plc
7.6.1 GlaxoSmithKline plc Business Overview
7.6.2 GlaxoSmithKline plc Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.6.3 GlaxoSmithKline plc Inhalation Spray-Based Drugs Product Introduction
7.6.4 GlaxoSmithKline plc Response to COVID-19 and Related Developments
7.7 Teva Pharmaceuticals
7.7.1 Teva Pharmaceuticals Business Overview
7.7.2 Teva Pharmaceuticals Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.7.3 Teva Pharmaceuticals Inhalation Spray-Based Drugs Product Introduction
7.7.4 Teva Pharmaceuticals Response to COVID-19 and Related Developments
7.8 AstraZeneca Plc.
7.8.1 AstraZeneca Plc. Business Overview
7.8.2 AstraZeneca Plc. Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.8.3 AstraZeneca Plc. Inhalation Spray-Based Drugs Product Introduction
7.8.4 AstraZeneca Plc. Response to COVID-19 and Related Developments
7.9 Opko Health
7.9.1 Opko Health Business Overview
7.9.2 Opko Health Inhalation Spray-Based Drugs Quarterly Production and Revenue, 2020
7.9.3 Opko Health Inhalation Spray-Based Drugs Product Introduction
7.9.4 Opko Health Response to COVID-19 and Related Developments

8 Supply Chain and Sales Channels Analysis
8.1 Inhalation Spray-Based Drugs Supply Chain Analysis
8.1.1 Inhalation Spray-Based Drugs Supply Chain Analysis
8.1.2 Covid-19 Impact on Inhalation Spray-Based Drugs Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Inhalation Spray-Based Drugs Distribution Channels
8.2.2 Covid-19 Impact on Inhalation Spray-Based Drugs Distribution Channels
8.2.3 Inhalation Spray-Based Drugs Distributors
8.3 Inhalation Spray-Based Drugs Customers

9 Key Findings

10 Appendix
10.1 About Us
10.2 Disclaimer
List of Tables

Table 1. Overview of the World Economic Outlook Projections

Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 7. Covid-19 Impact: Global Major Government Policy

Table 8. The Covid-19 Impact on Inhalation Spray-Based Drugs Assessment

Table 9. COVID-19 Impact: Inhalation Spray-Based Drugs Market Trends

Table 10. COVID-19 Impact Global Inhalation Spray-Based Drugs Market Size

Table 11. Global Inhalation Spray-Based Drugs Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)

Table 12. Global Inhalation Spray-Based Drugs Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Kg)

Table 13. Global Inhalation Spray-Based Drugs Quarterly Market Size, 2020 (US$ Million) & (MT)

Table 14. Global Inhalation Spray-Based Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

Table 15. Global Inhalation Spray-Based Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)

Table 16. Global Inhalation Spray-Based Drugs Market Growth Drivers

Table 17. Global Inhalation Spray-Based Drugs Market Restraints

Table 18. Global Inhalation Spray-Based Drugs Market Opportunities

Table 19. Global Inhalation Spray-Based Drugs Market Challenges

Table 20. Key Manufacturers Inhalation Spray-Based Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)

Table 21. Top Manufacturers, Inhalation Spray-Based Drugs Market Size, 2019 (MT) & (US$ Million)

Table 22. Inhalation Spray-Based Drugs Factory Price by Manufacturers 2020 (USD/Kg)

Table 23. Location of Key Manufacturers Inhalation Spray-Based Drugs Manufacturing Plants

Table 24. Key Manufacturers Inhalation Spray-Based Drugs Market Served

Table 25. Date of Key Manufacturers Enter into Inhalation Spray-Based Drugs Market

Table 26. Key Manufacturers Inhalation Spray-Based Drugs Product Type

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Inhalation Spray-Based Drugs Market Size by Type, 2020, (US$ Million)

Table 29. Global Inhalation Spray-Based Drugs Market Size by Type, 2020 (MT)

Table 30. Global Inhalation Spray-Based Drugs Price: by Type, 2020-2021 (USD/Kg)

Table 31. Global Inhalation Spray-Based Drugs Market Size by Application: 2020-2021 (US$ Million)

Table 32. Global Inhalation Spray-Based Drugs Market Size by Application, 2020-2021 (MT)

Table 33. Global Inhalation Spray-Based Drugs Price: by Application, 2020-2021 (USD/Kg)

Table 34. Global Inhalation Spray-Based Drugs Market Size by Region, 2019-2021 (US$ Million)

Table 35. Global Inhalation Spray-Based Drugs Market Size by Region, 2019-2021 (MT)

Table 36. By Country, North America Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million)

Table 37. By Country, North America Inhalation Spray-Based Drugs Market Size, 2019-2021 (MT)

Table 38. US Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 39. Canada Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

Table 41. By Country, Europe Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million)

Table 42. By Country, Europe Inhalation Spray-Based Drugs Market Size, 2019-2021 (MT)

Table 43. Germany Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 44. France Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 45. UK Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 46. Italy Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

Table 48. By Region, Asia-Pacific Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million)

Table 49. By Region, Asia-Pacific Inhalation Spray-Based Drugs Market Size, 2019-2021 (MT)

Table 50. China Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 51. Japan Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 52. South Korea Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 53. India Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 54. ASEAN Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 55. Latin America Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 56. Middle East and Africa Inhalation Spray-Based Drugs Market Size, 2019-2021 (US$ Million) & (MT)

Table 57. Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Business Overview

Table 58. Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 59. Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Inhalation Spray-Based Drugs Product

Table 60. Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Response to COVID-19 and Related Developments

Table 61. Allergan Plc. Business Overview

Table 62. Allergan Plc. Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 63. Allergan Plc. Inhalation Spray-Based Drugs Product

Table 64. Allergan Plc. Response to COVID-19 and Related Developments

Table 65. CHIESI Farmaceutici S.p.A Business Overview

Table 66. CHIESI Farmaceutici S.p.A Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 67. CHIESI Farmaceutici S.p.A Inhalation Spray-Based Drugs Product

Table 68. CHIESI Farmaceutici S.p.A Response to COVID-19 and Related Developments

Table 69. Serenity Pharmaceuticals, LLC Business Overview

Table 70. Serenity Pharmaceuticals, LLC Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 71. Serenity Pharmaceuticals, LLC Inhalation Spray-Based Drugs Product

Table 72. Serenity Pharmaceuticals, LLC Response to COVID-19 and Related Developments

Table 73. Boehringer Ingelheim GmbH Business Overview

Table 74. Boehringer Ingelheim GmbH Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 75. Boehringer Ingelheim GmbH Inhalation Spray-Based Drugs Product

Table 76. Boehringer Ingelheim GmbH Response to COVID-19 and Related Developments

Table 77. GlaxoSmithKline plc Business Overview

Table 78. GlaxoSmithKline plc Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 79. GlaxoSmithKline plc Inhalation Spray-Based Drugs Product

Table 80. GlaxoSmithKline plc Response to COVID-19 and Related Developments

Table 81. Teva Pharmaceuticals Business Overview

Table 82. Teva Pharmaceuticals Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 83. Teva Pharmaceuticals Inhalation Spray-Based Drugs Product

Table 84. Teva Pharmaceuticals Response to COVID-19 and Related Developments

Table 85. AstraZeneca Plc. Business Overview

Table 86. AstraZeneca Plc. Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 87. AstraZeneca Plc. Inhalation Spray-Based Drugs Product

Table 88. AstraZeneca Plc. Response to COVID-19 and Related Developments

Table 89. Opko Health Business Overview

Table 90. Opko Health Inhalation Spray-Based Drugs Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

Table 91. Opko Health Inhalation Spray-Based Drugs Product

Table 92. Opko Health Response to COVID-19 and Related Developments

Table 93. Inhalation Spray-Based Drugs Distributors List

Table 94. Inhalation Spray-Based Drugs Customers List

Table 95. Covid-19 Impact on Inhalation Spray-Based Drugs Customers

List of Figures

Figure 1. Inhalation Spray-Based Drugs Product Picture

Figure 2. Inhalation Spray-Based Drugs Market Segmentation

Figure 3. Research Objectives

Figure 4. Research Process

Figure 5. Data Triangulation

Figure 6. Research Approach

Figure 7. Commodity Prices-Metals Price Indices

Figure 8. Commodity Prices- Precious Metal Price Indices

Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

Figure 10. Commodity Prices- Food and Beverage Price Indices

Figure 11. Commodity Prices- Fertilizer Price Indices

Figure 12. Commodity Prices- Energy Price Indices

Figure 13. G20+: Economic Policy Responses to COVID-19

Figure 14. Global Inhalation Spray-Based Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

Figure 15. Global Inhalation Spray-Based Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

Figure 16. Global Inhalation Spray-Based Drugs Market Size, Quarterly Growth, 2020-2021 (%)

Figure 17. Global Inhalation Spray-Based Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)

Figure 18. Global Inhalation Spray-Based Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)

Figure 19. Global Inhalation Spray-Based Drugs Market Size Market Share by Region, 2019 VS 2020 (%)

Figure 20. United States Composite PMI and GDP

Figure 21. Eurozone Composite PMI and GDP

Figure 22. Eurozone Core v. Periphery PMI Output Indices

Figure 23. Core v. Periphery PMI Employment Indices

Figure 24. UK Composite PMI and GDP

Figure 25. Caixin China Composite Output Index

Figure 26. Caixin China General Services Business Activity Index

Figure 27. Japan Composite Output Index

Figure 28. South Korea Manufacturing PMI

Figure 29. India Composite Output Index

Figure 30. ASEAN Manufacturing PMI

Figure 31. By Region, Asia-Pacific Inhalation Spray-Based Drugs Market Size Market Share, 2019-2021

Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.)

Allergan Plc.

CHIESI Farmaceutici S.p.A

Serenity Pharmaceuticals, LLC

Boehringer Ingelheim GmbH

GlaxoSmithKline plc

Teva Pharmaceuticals

AstraZeneca Plc.

Opko Health

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $2600

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase